Elisabeth Leiderman
Director/Board Member bij BLUEBIRD BIO, INC.
Vermogen: 28 488 $ op 31-03-2024
Momenteel actieve connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| Lindsay Rosenwald | M | 68 | 15 jaar | |
| Andrew Obenshain | M | 51 | 8 jaar | |
| Martin Murphy | M | 55 | 10 jaar | |
| Martin Pulé | M | 51 | 10 jaar | |
| Nick Leschly | M | 51 | 14 jaar | |
| Christian Martin Itin | M | 59 | 10 jaar | |
| Mark Vachon | M | 65 | 10 jaar | |
| Christopher Krawtschuk | M | 51 | 2 jaar | |
| Malcolm Hoenlein | M | 80 | 10 jaar | |
| Linda Bain | F | 53 | 6 jaar | |
| David Brochu | M | - | 5 jaar | |
| John Berriman | M | 76 | 10 jaar | |
| Charlotte Jones-Burton | M | - | 2 jaar | |
| Alex Driggs | M | 48 | - | |
| Richard Colvin | M | 58 | 6 jaar | |
| Michael Weiss | M | 58 | 11 jaar | |
| John Agwunobi | M | 59 | 7 jaar | |
| Olivia Manser | F | - | 2 jaar | |
| Cynthia Butitta | F | 70 | 6 jaar | |
| Richard Paulson | M | 56 | 1 jaar | |
| Alexander Swan | M | - | 3 jaar | |
| Najoh Tita | F | - | 3 jaar | |
| Jimmie Harvey | M | 72 | 16 jaar | |
| Joseph Anderson | M | 65 | 8 jaar | |
| Thomas Klima | M | 52 | 3 jaar | |
| Dov Klein | M | 72 | 9 jaar | |
| Brent Rice | M | 58 | 3 jaar | |
| Andrea Walton | F | - | 2 jaar | |
| Julia Wilson | F | - | - | |
| Sarah Alspach | F | - | 3 jaar | |
| Veronica Hersberger | M | - | 1 jaar | |
| Courtney OLeary | F | - | - | |
| Jess Rowlands | F | - | 2 jaar | |
| Melissa Bonner | M | - | 3 jaar | |
| Ben Machielse | M | - |
Complexa, Inc.
 Complexa, Inc. Pharmaceuticals: MajorHealth Technology Complexa, Inc. operates as a biopharmaceutical company which engages on discovering and developing therapies for the treatment of severe and life-threatening fibrosis and inflammatory diseases. The firm focuses on two therapeutic areas: focal segmental glomerulosclerosis (FSGS) and pulmonary arterial hypertension (PAH), two rare diseases that can compromise the normal function of the kidney and the heart. The company was founded by Bruce A. Freeman, Raymond A. Miller, and Margaret M. Tarpey in 2008 and is headquartered in Berwyn, PA. | 6 jaar |
| Anne-Virginie Eggimann | M | 51 | 13 jaar | |
| Christopher Vann | M | 59 | 8 jaar | |
| Elizabeth Pingpank | F | - | 8 jaar | |
| Robert Azelby | M | 56 | - | |
| Robert Iannone | M | 57 | 1 jaar | |
| George Avgerinos | M | 71 | 11 jaar | |
| Robert Dolski | M | 54 | 1 jaar | |
| Joseph Vittiglio | M | 52 | 1 jaar | |
| Sara Nayeem | M | 75 |
Complexa, Inc.
Complexa, Inc. Pharmaceuticals: MajorHealth Technology Complexa, Inc. operates as a biopharmaceutical company which engages on discovering and developing therapies for the treatment of severe and life-threatening fibrosis and inflammatory diseases. The firm focuses on two therapeutic areas: focal segmental glomerulosclerosis (FSGS) and pulmonary arterial hypertension (PAH), two rare diseases that can compromise the normal function of the kidney and the heart. The company was founded by Bruce A. Freeman, Raymond A. Miller, and Margaret M. Tarpey in 2008 and is headquartered in Berwyn, PA. | 7 jaar |
| Gilles Nobécourt | M | 67 |
Complexa, Inc.
Complexa, Inc. Pharmaceuticals: MajorHealth Technology Complexa, Inc. operates as a biopharmaceutical company which engages on discovering and developing therapies for the treatment of severe and life-threatening fibrosis and inflammatory diseases. The firm focuses on two therapeutic areas: focal segmental glomerulosclerosis (FSGS) and pulmonary arterial hypertension (PAH), two rare diseases that can compromise the normal function of the kidney and the heart. The company was founded by Bruce A. Freeman, Raymond A. Miller, and Margaret M. Tarpey in 2008 and is headquartered in Berwyn, PA. | 7 jaar |
| William Young | M | 79 | 3 jaar | |
| Eric Rowinsky | M | 67 | 14 jaar | |
| Miranda Neville | F | - | 6 jaar |
Relatiegrafiek
Connectie in verschillende bedrijven
Oude connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| Jason Cole | M | 51 | 8 jaar | |
| Robyn Hunter | F | 62 | 11 jaar | |
| Gina Consylman | F | 52 | 1 jaar | |
| Glenn L. Cooper | M | 71 | 4 jaar | |
| Harlan Weisman | M | 71 | 1 jaar | |
| Bobby Sandage | M | 70 | 2 jaar | |
| Joshua M. Tarnoff | M | 60 |
Complexa, Inc.
Complexa, Inc. Pharmaceuticals: MajorHealth Technology Complexa, Inc. operates as a biopharmaceutical company which engages on discovering and developing therapies for the treatment of severe and life-threatening fibrosis and inflammatory diseases. The firm focuses on two therapeutic areas: focal segmental glomerulosclerosis (FSGS) and pulmonary arterial hypertension (PAH), two rare diseases that can compromise the normal function of the kidney and the heart. The company was founded by Bruce A. Freeman, Raymond A. Miller, and Margaret M. Tarpey in 2008 and is headquartered in Berwyn, PA. | 7 jaar |
| Noah Beerman | M | 62 | 2 jaar | |
| Francisco Salva | M | 53 |
Complexa, Inc.
Complexa, Inc. Pharmaceuticals: MajorHealth Technology Complexa, Inc. operates as a biopharmaceutical company which engages on discovering and developing therapies for the treatment of severe and life-threatening fibrosis and inflammatory diseases. The firm focuses on two therapeutic areas: focal segmental glomerulosclerosis (FSGS) and pulmonary arterial hypertension (PAH), two rare diseases that can compromise the normal function of the kidney and the heart. The company was founded by Bruce A. Freeman, Raymond A. Miller, and Margaret M. Tarpey in 2008 and is headquartered in Berwyn, PA. | 2 jaar |
| Raymond Tesi | M | 68 | 3 jaar | |
| Sara Nochur | M | 63 | 2 jaar | |
| Kapil Dhingra | M | 64 | 9 jaar | |
| Katherine Edna Breedis | F | 61 | - | |
| Matthew Foy | M | - | - | |
| Denice Torres | F | 64 | 1 jaar | |
| William R. Sellers | M | 63 | 2 jaar | |
| Gary Gemignani | M | 59 | 1 jaar | |
| Ramy Ibrahim | M | 49 | - | |
| Ravichandran Rao | M | - |
Complexa, Inc.
Complexa, Inc. Pharmaceuticals: MajorHealth Technology Complexa, Inc. operates as a biopharmaceutical company which engages on discovering and developing therapies for the treatment of severe and life-threatening fibrosis and inflammatory diseases. The firm focuses on two therapeutic areas: focal segmental glomerulosclerosis (FSGS) and pulmonary arterial hypertension (PAH), two rare diseases that can compromise the normal function of the kidney and the heart. The company was founded by Bruce A. Freeman, Raymond A. Miller, and Margaret M. Tarpey in 2008 and is headquartered in Berwyn, PA. | 1 jaar |
| Ronald Vigliotta | M | 51 | 5 jaar | |
| Helen C. Fu | F | - | - | |
| Alison Finger | F | 60 | 2 jaar | |
| Chip Baird | M | 52 | 2 jaar | |
| John Johnson | M | 66 | 3 jaar | |
| Wendy Dixon | M | 68 | 8 jaar | |
| William Carson | M | 65 | 2 jaar | |
| Xiao Qin Lu | M | 49 | 5 jaar | |
| Christine Poon | F | 71 | 2 jaar | |
| Peter Thompson | M | 64 | 3 jaar | |
| Dale Ritter | M | 73 | 2 jaar | |
| Cynthia Hu | M | 54 | 2 jaar | |
| James Murphy | M | 67 | 1 jaar | |
| Daniel Lynch | M | 65 | 10 jaar | |
| David Barrett | M | 48 | - | |
| Michael Rogers | M | 64 | 2 jaar | |
| Federica O’Brien | F | 66 |
Complexa, Inc.
Complexa, Inc. Pharmaceuticals: MajorHealth Technology Complexa, Inc. operates as a biopharmaceutical company which engages on discovering and developing therapies for the treatment of severe and life-threatening fibrosis and inflammatory diseases. The firm focuses on two therapeutic areas: focal segmental glomerulosclerosis (FSGS) and pulmonary arterial hypertension (PAH), two rare diseases that can compromise the normal function of the kidney and the heart. The company was founded by Bruce A. Freeman, Raymond A. Miller, and Margaret M. Tarpey in 2008 and is headquartered in Berwyn, PA. | 2 jaar |
| Edgar Braendle | M | - | 3 jaar | |
| Heather Wolff | F | - | - | |
| Dorota McKay | F | 42 | - | |
| Rafael Rizo-Patron | M | - |
Nomura Securities, Inc.
| 6 jaar |
| Philip Gregory | M | 53 | 6 jaar | |
| Jessica Whitten | F | 48 | 3 jaar | |
| Elizabeth A. Tarka | M | 57 |
Complexa, Inc.
Complexa, Inc. Pharmaceuticals: MajorHealth Technology Complexa, Inc. operates as a biopharmaceutical company which engages on discovering and developing therapies for the treatment of severe and life-threatening fibrosis and inflammatory diseases. The firm focuses on two therapeutic areas: focal segmental glomerulosclerosis (FSGS) and pulmonary arterial hypertension (PAH), two rare diseases that can compromise the normal function of the kidney and the heart. The company was founded by Bruce A. Freeman, Raymond A. Miller, and Margaret M. Tarpey in 2008 and is headquartered in Berwyn, PA. | 2 jaar |
| Marcela Maus | M | 48 | - | |
| Evan Renov | M | - | 2 jaar | |
| Sarah Glickman | F | 54 | 1 jaar | |
| Anthony Philippakis | M | 48 | 3 jaar | |
| Murat Omur | M | 46 |
Nomura Securities, Inc.
| 4 jaar |
| Kevin J. Horgan | M | 64 | 1 jaar | |
| Diane Jorkasky | M | 72 |
Complexa, Inc.
Complexa, Inc. Pharmaceuticals: MajorHealth Technology Complexa, Inc. operates as a biopharmaceutical company which engages on discovering and developing therapies for the treatment of severe and life-threatening fibrosis and inflammatory diseases. The firm focuses on two therapeutic areas: focal segmental glomerulosclerosis (FSGS) and pulmonary arterial hypertension (PAH), two rare diseases that can compromise the normal function of the kidney and the heart. The company was founded by Bruce A. Freeman, Raymond A. Miller, and Margaret M. Tarpey in 2008 and is headquartered in Berwyn, PA. | 5 jaar |
| Karin Hehenberger | M | 52 | 2 jaar | |
| Jenny Marlowe | M | 47 | 1 jaar |
Statistieken
| Land | Connecties | % van het totaal |
|---|---|---|
| Verenigde Staten | 77 | 77.00% |
| Verenigd Koninkrijk | 23 | 23.00% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Elisabeth Leiderman
- Persoonlijk netwerk
